摘要
目的 探究低分子肝素联合阿司匹林对PTS致复发性流产母婴结局及血栓检验性指标的影响。方法 纳入86例PTS致复发性流产在本院治疗的患者,(时间:2019年12月~2020年12月),行治疗对比性研究,电脑排列数组分组,对照组(阿司匹林治疗,n=43),实验组(低分子肝素联合阿司匹林治疗,n=43),分析两组患者(1)血栓检测指标水平(D-二聚体(D-Dimer)、凝血酶时间(TT)、狼疮样抗凝物质(LA)与正常值对比(LAR));(2)妊娠结局对比;(3)新生儿健康状况。(4)药物不良反应发生率(腹胀、腹泻、恶心呕吐、血小板减少、新生儿畸形)。结果 (1)血栓检测指标水平:实验组D-Dimer、TT、LAR,较对照组差异显著,(P<0.05);(2)妊娠结局:实验组较对照组,改善显著,(P<0.05);(3)新生儿健康状况:实验组较对照组,分娩孕周、出生体重、Apgar评分无明显差异,(P>0.05)。(4)药物不良反应发生率:实验组腹胀、腹泻、恶心呕吐、血小板减少、新生儿畸形等药物不良反应发生率较对照组,数据存在显著降低意义,(P>0.05)。结论 低分子肝素联合阿司匹林对PTS致复发性流产患者,有较好的治疗效果,改善母婴结局以及血栓检验性指标,有临床推广意义。
Objective To explore the effect of low molecular weight heparin combined with aspirin on maternal and infant outcomes and thrombosis test indicators of recurrent miscarriage caused by PTS.Methods A total of 86 patients with PTS-induced recurrent miscarriage treated in our hospital were included(time:December 2019 to December 2020) for a comparative study of treatment,grouped by computer array,and the control group(aspirin treatment,n=43),the experimental group(low molecular weight heparin combined with aspirin,n=43),the two groups of patients were analyzed(1) thrombus detection index levels(D-dimer(D-Dimer),thrombin time(TT),lupus-like Comparison of anticoagulant substances(LA) and normal values(LAR));(2) comparison of pregnancy outcomes;(3) neonatal health status.(4) The incidence of adverse drug reactions(abdominal distention,diarrhea,nausea and vomiting,thrombocytopenia,neonatal malformation).Results(1) Thrombus detection index levels:D-Dimer,TT,LAR in the experimental group were significantly different from those in the control group(P<0.05);(2) Pregnancy outcome:the experimental group was significantly improved compared with the control group(P<0.05);(3) Neonatal health status:There was no significant difference in gestational age,birth weight and Apgar score between the experimental group and the control group(P>0.05).(4) Incidence of adverse drug reactions:The incidence of adverse drug reactions such as abdominal distension,diarrhea,nausea and vomiting,thrombocytopenia,and neonatal malformation in the experimental group was significantly lower than that in the control group(P>0.05).Conclusions Low molecular weight heparin combined with aspirin has a good therapeutic effect on patients with recurrent miscarriage caused by PTS,improves maternal and infant outcomes and thrombus test indicators,and is of clinical significance.
作者
刘红霞
LIU Hongxia(Qingfeng Second People’s Hospital Puyang City,Henan Province,457300)
出处
《航空航天医学杂志》
2022年第3期274-276,共3页
Journal of Aerospace medicine
关键词
低分子肝素
阿司匹林
PTS
复发性流产
母婴结局
血栓检验性指标
low molecular weight heparin
aspirin
PTS
recurrent miscarriage
maternal and infant outcome
thrombus test index